---
figid: PMC11063389__fonc-14-1381251-g002
figtitle: Therapeutic targets and inhibitors targeting JAK2/STAT3 signaling pathway
  for TNBC treatment
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11063389
filename: fonc-14-1381251-g002.jpg
figlink: /pmc/articles/PMC11063389/figure/F2
number: F2
caption: 'Potential therapeutic targets and inhibitors targeting JAK2/STAT3 signaling
  pathway for TNBC treatment. Occupation-driven mode: RTKs, JAK2 and STAT3-targeted
  inhibitors; event driven mode: small molecule compounds targeting JAK2 protein for
  ubiquitination degradation'
papertitle: Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative
  breast cancer
reftext: Lin Long, et al. Front Oncol. 2024;14(NA).
year: '2024'
doi: 10.3389/fonc.2024.1381251
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: triple-negative breast cancer | receptor tyrosine kinase | Janus Kinase
  2 | signal transducer and activator of transcription 3 | small molecule compounds
automl_pathway: 0.9303097
figid_alias: PMC11063389__F2
figtype: Figure
redirect_from: /figures/PMC11063389__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11063389__fonc-14-1381251-g002.html
  '@type': Dataset
  description: 'Potential therapeutic targets and inhibitors targeting JAK2/STAT3
    signaling pathway for TNBC treatment. Occupation-driven mode: RTKs, JAK2 and STAT3-targeted
    inhibitors; event driven mode: small molecule compounds targeting JAK2 protein
    for ubiquitination degradation'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADHFE1
  - GAA
  - JAK2
  - DYM
  - CXCL17
  - STAT3
  - TPO
  - Gefitinib
  - N-N
  - Ruxolitinib
  - Silibinin
  - AG490
  - Chloroquine
  - Doxazosin
  - Piperlongumine
  - Magnolol
  - JAK2 inhibitors
  - Erlotinib
  - DMC
  - Primaquine
  - STAT3 inhibitors
  - Salidroside
  - Naringenin
  - Hydroxyzine
  - S31-201
  - -OH
---
